Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis

Wenzel M. Hackeng, Lodewijk A A Brosens, Katherine E. Poruk, Michaël Noë, Waki Hosoda, Justin S. Poling, Anthony Rizzo, Martha Campbell-Thompson, Mark A. Atkinson, Björn Konukiewitz, Günter Klöppel, Christopher M Heaphy, Alan Keith Meeker, Laura Delong Wood

Research output: Contribution to journalArticle

Abstract

Pancreatic neuroendocrine tumors (PanNETs) are the second most common pancreatic malignancy and cause significant morbidity and mortality. Neuroendocrine microadenomas have been proposed as a potential precursor lesion for sporadic PanNETs. In this study, we applied telomere-specific fluorescent in situ hybridization (FISH) to a series of well-characterized sporadic neuroendocrine microadenomas and investigated the prevalence of alterations in known PanNET driver genes (MEN1 and ATRX/DAXX) in these same tumors using immunohistochemistry for the encoded proteins. We identified aberrant Menin expression in 14 of 19 (74%) microadenomas, suggesting that alterations in Menin, at least a subset of which was likely due to somatic mutation, are early events in pancreatic neuroendocrine tumorigenesis. In contrast, none of the microadenomas met criteria for the alternative lengthening of telomeres phenotype (ALT) based on telomere FISH, a phenotype that is strongly correlated to ATRX or DAXX mutations. Two of 13 microadenomas (15%) were noted to have very rare abnormal bright telomere foci on FISH, suggestive of early ALT, but these lesions did not show loss of ATRX or DAXX protein expression by immunohistochemistry. Overall, these data suggest that loss of Menin is an early event in pancreatic neuroendocrine tumorigenesis and that ATRX/DAXX loss and ALT are relatively late events.

Original languageEnglish (US)
Pages (from-to)93-100
Number of pages8
JournalHuman Pathology
Volume56
DOIs
StatePublished - Oct 1 2016

Fingerprint

Telomere Homeostasis
Neuroendocrine Tumors
Telomere
Carcinogenesis
Fluorescence In Situ Hybridization
Phenotype
Immunohistochemistry
Multiple Endocrine Neoplasia Type 1
Mutation
Neoplasms
Proteins
Morbidity
Mortality
Genes

Keywords

  • ATRX
  • DAXX
  • Menin
  • Microadenoma
  • PanNET
  • Tumorigenesis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Hackeng, W. M., Brosens, L. A. A., Poruk, K. E., Noë, M., Hosoda, W., Poling, J. S., ... Wood, L. D. (2016). Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis. Human Pathology, 56, 93-100. https://doi.org/10.1016/j.humpath.2016.06.006

Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis. / Hackeng, Wenzel M.; Brosens, Lodewijk A A; Poruk, Katherine E.; Noë, Michaël; Hosoda, Waki; Poling, Justin S.; Rizzo, Anthony; Campbell-Thompson, Martha; Atkinson, Mark A.; Konukiewitz, Björn; Klöppel, Günter; Heaphy, Christopher M; Meeker, Alan Keith; Wood, Laura Delong.

In: Human Pathology, Vol. 56, 01.10.2016, p. 93-100.

Research output: Contribution to journalArticle

Hackeng, WM, Brosens, LAA, Poruk, KE, Noë, M, Hosoda, W, Poling, JS, Rizzo, A, Campbell-Thompson, M, Atkinson, MA, Konukiewitz, B, Klöppel, G, Heaphy, CM, Meeker, AK & Wood, LD 2016, 'Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis', Human Pathology, vol. 56, pp. 93-100. https://doi.org/10.1016/j.humpath.2016.06.006
Hackeng, Wenzel M. ; Brosens, Lodewijk A A ; Poruk, Katherine E. ; Noë, Michaël ; Hosoda, Waki ; Poling, Justin S. ; Rizzo, Anthony ; Campbell-Thompson, Martha ; Atkinson, Mark A. ; Konukiewitz, Björn ; Klöppel, Günter ; Heaphy, Christopher M ; Meeker, Alan Keith ; Wood, Laura Delong. / Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis. In: Human Pathology. 2016 ; Vol. 56. pp. 93-100.
@article{1a538f58627c443dadd4585126fce7f6,
title = "Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis",
abstract = "Pancreatic neuroendocrine tumors (PanNETs) are the second most common pancreatic malignancy and cause significant morbidity and mortality. Neuroendocrine microadenomas have been proposed as a potential precursor lesion for sporadic PanNETs. In this study, we applied telomere-specific fluorescent in situ hybridization (FISH) to a series of well-characterized sporadic neuroendocrine microadenomas and investigated the prevalence of alterations in known PanNET driver genes (MEN1 and ATRX/DAXX) in these same tumors using immunohistochemistry for the encoded proteins. We identified aberrant Menin expression in 14 of 19 (74{\%}) microadenomas, suggesting that alterations in Menin, at least a subset of which was likely due to somatic mutation, are early events in pancreatic neuroendocrine tumorigenesis. In contrast, none of the microadenomas met criteria for the alternative lengthening of telomeres phenotype (ALT) based on telomere FISH, a phenotype that is strongly correlated to ATRX or DAXX mutations. Two of 13 microadenomas (15{\%}) were noted to have very rare abnormal bright telomere foci on FISH, suggestive of early ALT, but these lesions did not show loss of ATRX or DAXX protein expression by immunohistochemistry. Overall, these data suggest that loss of Menin is an early event in pancreatic neuroendocrine tumorigenesis and that ATRX/DAXX loss and ALT are relatively late events.",
keywords = "ATRX, DAXX, Menin, Microadenoma, PanNET, Tumorigenesis",
author = "Hackeng, {Wenzel M.} and Brosens, {Lodewijk A A} and Poruk, {Katherine E.} and Micha{\"e}l No{\"e} and Waki Hosoda and Poling, {Justin S.} and Anthony Rizzo and Martha Campbell-Thompson and Atkinson, {Mark A.} and Bj{\"o}rn Konukiewitz and G{\"u}nter Kl{\"o}ppel and Heaphy, {Christopher M} and Meeker, {Alan Keith} and Wood, {Laura Delong}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.humpath.2016.06.006",
language = "English (US)",
volume = "56",
pages = "93--100",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis

AU - Hackeng, Wenzel M.

AU - Brosens, Lodewijk A A

AU - Poruk, Katherine E.

AU - Noë, Michaël

AU - Hosoda, Waki

AU - Poling, Justin S.

AU - Rizzo, Anthony

AU - Campbell-Thompson, Martha

AU - Atkinson, Mark A.

AU - Konukiewitz, Björn

AU - Klöppel, Günter

AU - Heaphy, Christopher M

AU - Meeker, Alan Keith

AU - Wood, Laura Delong

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Pancreatic neuroendocrine tumors (PanNETs) are the second most common pancreatic malignancy and cause significant morbidity and mortality. Neuroendocrine microadenomas have been proposed as a potential precursor lesion for sporadic PanNETs. In this study, we applied telomere-specific fluorescent in situ hybridization (FISH) to a series of well-characterized sporadic neuroendocrine microadenomas and investigated the prevalence of alterations in known PanNET driver genes (MEN1 and ATRX/DAXX) in these same tumors using immunohistochemistry for the encoded proteins. We identified aberrant Menin expression in 14 of 19 (74%) microadenomas, suggesting that alterations in Menin, at least a subset of which was likely due to somatic mutation, are early events in pancreatic neuroendocrine tumorigenesis. In contrast, none of the microadenomas met criteria for the alternative lengthening of telomeres phenotype (ALT) based on telomere FISH, a phenotype that is strongly correlated to ATRX or DAXX mutations. Two of 13 microadenomas (15%) were noted to have very rare abnormal bright telomere foci on FISH, suggestive of early ALT, but these lesions did not show loss of ATRX or DAXX protein expression by immunohistochemistry. Overall, these data suggest that loss of Menin is an early event in pancreatic neuroendocrine tumorigenesis and that ATRX/DAXX loss and ALT are relatively late events.

AB - Pancreatic neuroendocrine tumors (PanNETs) are the second most common pancreatic malignancy and cause significant morbidity and mortality. Neuroendocrine microadenomas have been proposed as a potential precursor lesion for sporadic PanNETs. In this study, we applied telomere-specific fluorescent in situ hybridization (FISH) to a series of well-characterized sporadic neuroendocrine microadenomas and investigated the prevalence of alterations in known PanNET driver genes (MEN1 and ATRX/DAXX) in these same tumors using immunohistochemistry for the encoded proteins. We identified aberrant Menin expression in 14 of 19 (74%) microadenomas, suggesting that alterations in Menin, at least a subset of which was likely due to somatic mutation, are early events in pancreatic neuroendocrine tumorigenesis. In contrast, none of the microadenomas met criteria for the alternative lengthening of telomeres phenotype (ALT) based on telomere FISH, a phenotype that is strongly correlated to ATRX or DAXX mutations. Two of 13 microadenomas (15%) were noted to have very rare abnormal bright telomere foci on FISH, suggestive of early ALT, but these lesions did not show loss of ATRX or DAXX protein expression by immunohistochemistry. Overall, these data suggest that loss of Menin is an early event in pancreatic neuroendocrine tumorigenesis and that ATRX/DAXX loss and ALT are relatively late events.

KW - ATRX

KW - DAXX

KW - Menin

KW - Microadenoma

KW - PanNET

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84979683916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979683916&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2016.06.006

DO - 10.1016/j.humpath.2016.06.006

M3 - Article

VL - 56

SP - 93

EP - 100

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

ER -